General Information of the Compound
Compound ID |
CP0049482
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-(2,5-diphenylpyrazol-3-yl)benzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
77746-90-8
AC1N4KII
AKOS005002190
BDBM50156065
Benzamide, N-(1,3-diphenyl-1H-pyrazol-5-yl)-
CHEMBL191039
CTK2G6100
DA-03411
DTXSID00400046
FT-0732104
HMS3519K01
MCULE-3316862201
MolPort-003-805-392
N-(1,3-Diphenyl-1H-pyrazole-5-yl)benzamide
N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
N-(2,5-Diphenyl-2H-pyrazol-3-yl)-benzamide
N-(2,5-diphenylpyrazol-3-yl)benzamide
Oprea1_790904
SCHEMBL2482825
ZINC3185886
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C22H17N3O
|
||||||||||||||||||
Molecular Weight |
339.398
|
||||||||||||||||||
Canonical SMILES |
O=C(Nc1cc(nn1-c1ccccc1)-c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C22H17N3O/c26-22(18-12-6-2-7-13-18)23-21-16-20(17-10-4-1-5-11-17)24-25(21)19-14-8-3-9-15-19/h1-16H,(H,23,26)
Show/Hide
|
||||||||||||||||||
InChIKey |
AYVLYDAJDALPHK-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00854, Metabotropic glutamate receptor 5
Protein ID: PT01247, Metabotropic glutamate receptor 5
Clinical Information about the Compound